Clinical Trials Browser

Phase 2 × Solid Tumor × toripalimab × Clear all

NCT03810339 2026-04-23

Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor